Who
Merilee Raines
Director
Company insider
Files Form 4 as: Director, Watts Water Technologies; Director, Ocular Therapeutix; Director, TransMedics Group; Director, Benchmark Electronics; Director, Aratana Therapeutics; Director, Affymetrix; Executive VP & CFO, IDEXX Laboratories.
In numbers
- Trades disclosed
- 281
- Buys
- 0
- Sells
- 21
- Bought
- $0
- Sold
- $39.6M
- Companies
- 7
- Companies where not an officer
- 6
- First trade
- 13 Jan 2006
- Last trade
- 3 Aug 2026
- Last filed
- 4 Aug 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 3 Aug 2026filed 4 Aug 2026 | WTS Watts Water TechnologiesMachinery | SEC FORM 4 Code A | —456 at $0.00 | filing |
| 3 Aug 2026filed 4 Aug 2026 | WTS Watts Water TechnologiesMachinery | SEC FORM 4 Code A | —456 at $0.00 | filing |
| 10 Jun 2026filed 12 Jun 2026 | OCUL Ocular TherapeutixBiotechnology | SEC FORM 4 Code A | —14,000 at $0.00 | filing |
| 10 Jun 2026filed 12 Jun 2026 | OCUL Ocular Therapeutixoption or derivative · Biotechnology | SEC FORM 4 Code A | —44,000 at $0.00 | filing |
| 10 Jun 2026filed 12 Jun 2026 | OCUL Ocular Therapeutixoption or derivative · Biotechnology | SEC FORM 4 Code A | —44,000 at $0.00 | filing |
| 10 Jun 2026filed 12 Jun 2026 | OCUL Ocular TherapeutixBiotechnology | SEC FORM 4 Code A | —14,000 at $0.00 | filing |
| 20 May 2026filed 22 May 2026 | TMDX TransMedics GroupMedical Devices | SEC FORM 4 Code A | —2,922 at $0.00 | filing |
| 20 May 2026filed 22 May 2026 | TMDX TransMedics GroupMedical Devices | SEC FORM 4 Code A | —2,922 at $0.00 | filing |
| 5 Aug 2025filed 5 Aug 2025 | WTS Watts Water TechnologiesMachinery | SEC FORM 4 Code A | —516 at $0.00 | filing |
| 11 Jun 2025filed 13 Jun 2025 | OCUL Ocular Therapeutixoption or derivative · Biotechnology | SEC FORM 4 Code A | —44,000 at $0.00 | filing |
| 11 Jun 2025filed 13 Jun 2025 | OCUL Ocular TherapeutixBiotechnology | SEC FORM 4 Code A | —14,000 at $0.00 | filing |
| 22 May 2025filed 23 May 2025 | TMDX TransMedics GroupMedical Devices | SEC FORM 4 Code A | —2,134 at $0.00 | filing |
| 5 Aug 2024filed 5 Aug 2024 | WTS Watts Water TechnologiesMachinery | SEC FORM 4 Code A | —678 at $0.00 | filing |
| 24 Jul 2024filed 26 Jul 2024 | OCUL Ocular Therapeutixoption or derivative · Biotechnology | SEC FORM 4 Code A | —36,000 at $0.00 | filing |
| 24 Jul 2024filed 26 Jul 2024 | OCUL Ocular TherapeutixBiotechnology | SEC FORM 4 Code A | —12,000 at $0.00 | filing |
| 23 May 2024filed 28 May 2024 | TMDX TransMedics Groupoption or derivative · Medical Devices | SEC FORM 4 Code A | —1,154 at $0.00 | filing |
| 23 May 2024filed 28 May 2024 | TMDX TransMedics GroupMedical Devices | SEC FORM 4 Code A | —732 at $0.00 | filing |
| 31 Jul 2023filed 31 Jul 2023 | WTS Watts Water TechnologiesMachinery | SEC FORM 4 Code A | —713 at $0.00 | filing |
| 14 Jun 2023filed 16 Jun 2023 | OCUL Ocular Therapeutixoption or derivative · Biotechnology | SEC FORM 4 Code A | —36,000 at $0.00 | filing |
| 14 Jun 2023filed 16 Jun 2023 | OCUL Ocular TherapeutixBiotechnology | SEC FORM 4 Code A | —12,000 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.